Greenfield Seitz Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
16,148
-1,054
-6% -$70.2K 0.32% 58
2026
Q1
$1.08M Sell
17,202
-6,662
-28% -$464K 0.33% 61
2025
Q4
$1.58M Sell
23,864
-40,317
-63% -$2.61M 0.52% 50
2025
Q3
$4.32M Buy
64,181
+3,387
+6% +$268K 1.39% 26
2025
Q2
$5.31M Buy
60,794
+2,042
+3% +$160K 1.88% 19
2025
Q1
$4.01M Sell
58,752
-85
-0.1% -$6.94K 1.53% 27
2024
Q4
$4.58M Sell
58,837
-900
-2% -$66.6K 1.74% 23
2024
Q3
$4M Buy
59,737
+5,739
+11% +$471K 1.47% 26
2024
Q2
$6.12M Buy
53,998
+4,651
+9% +$588K 2.27% 13
2024
Q1
$6.84M Sell
49,347
-1,392
-3% -$175K 2.55% 11
2023
Q4
$6.3M Buy
+50,739
New +$5.18M 2.51% 9

Other funds holding DXCM

Greenfield Seitz Capital Management's DXCM Position: Q2 2026 in Review

Greenfield Seitz Capital Management reduced its DexCom (DXCM) stake by 6.1% in Q2 2026, selling an estimated $70.2K and leaving 16,148 shares worth $1.09M. The position accounts for 0.32% of the portfolio, ranked #58.

Greenfield Seitz Capital Management first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.84M in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Greenfield Seitz Capital Management held 16,148 shares of DexCom worth $1.09M as of Q2 2026.
  • Greenfield Seitz Capital Management sold 1,054 DexCom shares in Q2 2026, an estimated $70.2K.
  • DexCom made up 0.32% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #58 holding.
  • Greenfield Seitz Capital Management first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Greenfield Seitz Capital Management's DexCom position peaked at $6.84M in Q1 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.